ZEAL&
LIVE

Serial Number

79428652

Owner

ZEALAND PHARMA A/S

Attorney

Miriam D. Trudell

Filing Date

May 27, 2025

Add to watchlist:

No watchlists yet
View on USPTO

ZEAL& Trademark

Serial Number: 79428652

ZEAL& is a trademark filed by ZEALAND PHARMA A/S on May 27, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

ZEALAND PHARMA A/S (41 trademarks)

SØBORG 2860 , DK

Entity Type: 03

Trademark Details

Filing Date

May 27, 2025

Registration Date

Not Registered

Goods & Services

Medical and surgical apparatus and instruments; medical apparatus and instruments for reconstitution and injection of pharmaceutical preparations; medical apparatus and instruments, namely, injection devices for administration of pharmaceutical preparations, medical infusion pumps, infusion pump controllers, adhesive infusion devices; digitally connected medical devices for monitoring the dispensation of pharmaceutical preparations for use in connection with the management of diseases and illnesses in the human body; medical and surgical apparatus and instruments, namely, injection devices for the administration of pharmaceutical preparations and the wireless transmission of medical data in connection with the management of diseases and illnesses in the human body; medical devices, namely, automatic needle insertion devices, protection caps for syringes and medical pens; hypodermic needles for injections; cartridges and carpules, sold empty, for administration pharmaceutical preparations

Downloadable electronic publications, namely, leaflets, books, booklets, handouts, magazines as well as medical, instructional and teaching material, all in the field of diabetes, obesity, and gastrointestinal diseases; downloadable software applications for use with mobile devices for monitoring and the management of diseases and illnesses in human beings; computer hardware and downloadable software, for use with medical injection devices for collecting, transmitting, and displaying medical data; downloadable medical software for the management of diseases and illnesses in human beings; downloadable software intended for medical purposes that perform these purposes without being part of a medical device, namely, for monitoring and managing diseases in humans

Providing medical services via websites and mobile apps for the management of diseases and illnesses in the human body; providing medical information and medical counselling relating to the management of diseases and illnesses in the human body.

Pharmaceutical preparations for the treatment of diseases and disorders in humans, namely, endocrine, nutritional, metabolic, immune, blood, nervous system, sensory organ, musculoskeletal, connective tissue, circulatory, respiratory, digestive, genitourinary, and skin disorders, diabetes, obesity, gastrointestinal diseases and conditions such as Congenital HyperInsulinism (CHI), hypoglycemia, Short Bowel Syndrome (SBS), and chronic inflammation, Inflammatory Bowel Disease (IBD) and Metabolic dysfunction-associated steatohepatitis (MASH); delivery devices containing pharmaceutical products, namely, syringes sold filled with pharmaceutical preparations the treatment of diseases and disorders in humans, namely, endocrine, nutritional, metabolic, immune, blood, nervous system, sensory organ, musculoskeletal, connective tissue, circulatory, respiratory, digestive, genitourinary, and skin disorders, diabetes, obesity, gastrointestinal diseases and conditions such as Congenital HyperInsulinism (CHI), hypoglycemia, Short Bowel Syndrome (SBS), and chronic inflammation, Inflammatory Bowel Disease (IBD) and Metabolic dysfunction-associated steatohepatitis (MASH); chemical preparations for use in medical devices, namely, chemical preparations for pharmaceutical purposes for the treatment of diseases and disorders in humans, namely, endocrine, nutritional, metabolic, immune, blood, nervous system, sensory organ, musculoskeletal, connective tissue, circulatory, respiratory, digestive, genitourinary, and skin disorders, diabetes, obesity, gastrointestinal diseases and conditions such as Congenital HyperInsulinism (CHI), hypoglycemia, Short Bowel Syndrome (SBS), and chronic inflammation, Inflammatory Bowel Disease (IBD) and Metabolic dysfunction-associated steatohepatitis (MASH)

Scientific and technological services and research and design relating thereto, namely, scientific research and development in the field of medicine, pharmaceuticals, genetics, biology and biotechnology; providing scientific research information on diseases and illnesses in the human body; providing websites and hosting of mobile apps featuring technology that enable users to record, track, and generate reports regarding the condition, treatment and the management of diseases and illnesses in the human body; computer services, namely, providing a website featuring technology enabling users to access data concerning medical analysis and management of diseases and illnesses in the human body; scientific industrial analysis and research services in the field of medicine, pharmaceuticals, genetics, biology and biotechnology; medical, biological, biotechnological, genetic, medical laboratory research and pharmaceutical research, pharmaceutical design and development services; medical laboratory research in the field of medicine, pharmaceuticals, genetics, biology and biotechnology; information and consultancy services relating to all the aforesaid

Filing History

TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 12, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 12, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 12, 2026 TROA
REFUSAL PROCESSED BY IB
Jan 1, 2026 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 17, 2025 RFCS
REFUSAL PROCESSED BY MPU
Dec 16, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 16, 2025 RFCR
NON-FINAL ACTION WRITTEN
Oct 15, 2025 CNRT
ASSIGNED TO EXAMINER
Oct 14, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 1, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 1, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 24, 2025 REPR